Home > Boards > US OTC > Cannabis >

Cannabix Technologies Inc. (BLOZF)

BLOZF RSS Feed
Add BLOZF Price Alert      Hide Sticky   Hide Intro
Moderator: shell3
Search This Board: 
Last Post: 5/14/2022 1:34:20 PM - Followers: 331 - Board type: Free - Posts Today: 0






Cannabix Technologies Inc.

(CSE: BLO    US OTC: BLOZF    
Frankfurt: 8CT:FRA)
 

Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.


Cannabix Technologies Inc. has
Worldwide Rights to
"
Partial ovoidal FAIMS electrode"
Patent 8,237,118
from the University of Florida

WORLDWIDE RIGHTS
for 

CONTROLLED SUBSTANCE

Rights for 10 Years after 1st Product sold



What is FAIMS-MS?


It Blocks Out Unwanted Molecules
 Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost

https://www.msacl.org/index.php?header=Learning_Center&tab=Video_Management&subtab=Video_Request&id=8&conference=2015_US&type=plenary

 
 
US Patent Application
http://www.freshpatents.com/-dt20151029ptan20150305651.php


APPLIED 2014 GRANTED 2021


Canada Patent Application
http://www.ic.gc.ca/opic-cipo/cpd/eng/patent/2887841/summary.html?query=Cannabix&start=1&num=50&type=basic_search
 

Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana.  Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions.  Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing 


http://www.cannabixtechnologies.com/

 
Outstanding Shares
105,124,104
10/06/2020
 100,567,054
 05/05/
2018
 
Cannabix Corporate Video
https://www.youtube.com/watch?v=ix3Uss9zrBo
Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc.  Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development.  Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD.,  Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products.  Dr.  Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.

Dr. Bruce Goldberger, PhD,  Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida.  Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.

Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Jared Boock Ph.D, Principal investigator
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.

Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).

Rav Mlait, MBA – CEO, Director
.Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.

Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.


Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge. 

 
Andrew Davies,  Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016).  Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine. 





 
BLOZF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BLOZF News: Cannabix Technologies Correlates THC in Breath and Blood using Proprietary Sample Collection and Analysis Hardware in Experimental Study 05/09/2022 04:45:00 AM
BLOZF News: Cannabix Technologies Creates Contactless Alcohol Breath Detection Technology for Vehicles - Files Provisional Patent 04/20/2022 04:45:00 AM
BLOZF News: Cannabix Technologies to Present at International Association for Chemical Testing (IACT) Conference in Arizona 04/12/2022 04:50:00 AM
BLOZF News: Cannabix Technologies Presents FAIMS Marijuana Breathalyzer Technology at the Texas Impaired Driving Forum 02/24/2022 03:50:00 AM
BLOZF News: Cannabix Technologies Develops Version 4.0 of THC Breath Analyzer Device 02/01/2022 03:45:00 AM
PostSubject
#27152  Sticky Note Outstanding: 114,144,104 for November 5, 2021 shell3 11/04/21 06:10:24 PM
#27307   Enjoy ur weekend... Money $hot 05/14/22 01:34:20 PM
#27306   Well everyone, something big must be on the Carthnel 05/14/22 08:03:16 AM
#27305   You have a poor memory AND your analogy Money $hot 05/12/22 02:54:29 PM
#27304   Your right let’s see where life loc is Carthnel 05/12/22 01:54:28 PM
#27303   After 8 years of you following the story Money $hot 05/12/22 12:52:37 PM
#27302   I was so excited I missed the ? Carthnel 05/12/22 12:06:15 PM
#27301   Wow “to develop”,well good luck to them ! Carthnel 05/12/22 12:05:34 PM
#27300   Our most important goal remains the convergence of Money $hot 05/12/22 11:54:01 AM
#27299   Thus thanks for the advice. I will buy Carthnel 05/12/22 09:21:06 AM
#27297   Let’s see why would you hold a stock Carthnel 05/12/22 09:18:28 AM
#27296   Recap: Hey Cart! Folks would love to see Money $hot 05/11/22 03:56:20 PM
#27295   Your right money’s shot I’m buying more Carthnel 05/11/22 10:12:13 AM
#27294   Do yourself some real Due Diligence here: Money $hot 05/09/22 09:52:43 PM
#27292   They continue to move their arbitrary timeline for Money $hot 05/09/22 01:08:07 PM
#27291   She’s no longer listed on $BLOZF Advisors but shell3 05/09/22 12:17:31 PM
#27290   Understand where you stand in the pecking order. Money $hot 05/09/22 11:17:38 AM
#27289   ...yeah they've been BLO-ing since 2015 right? Money $hot 05/09/22 10:33:49 AM
#27288   Regarding the latest NR: If you throw out Money $hot 05/09/22 10:23:30 AM
#27287   I say BINGO like $BLOZF gonna $BLO shell3 05/09/22 10:05:17 AM
#27286   “The man called his wife’s name Eve, because Money $hot 05/08/22 10:51:58 AM
#27285   On Tomorrow: Happy Mother's Day To All Mother's Money $hot 05/07/22 09:24:07 AM
#27284   Week long 100,000 shares firewall/bid @ 40 cents Money $hot 05/06/22 02:14:44 PM
#27283   Algorithms likely continue to hold up the fake Money $hot 05/05/22 02:12:33 PM
#27282   Outstanding: 114,144,104 for May 5, 2022 shell3 05/05/22 08:20:52 AM
#27281   Somebody please let me know when Cannabix will Money $hot 04/29/22 03:29:19 PM
#27280   Team Cannabix or...? Money $hot 04/25/22 08:55:04 PM
#27279   Tweet tweet CFN .) Blozf is gonna rocket ! Carthnel 04/25/22 01:55:46 PM
#27278   Your right money’s shot Canabix will shine. I’ll Carthnel 04/21/22 05:50:50 PM
#27277   You're making up your own conclusions about the Money $hot 04/21/22 02:17:56 PM
#27275   I mean obviously if you say the tech Carthnel 04/21/22 01:25:42 PM
#27274   Projection? You're the funny one. I'm a realist. Money $hot 04/21/22 01:06:20 PM
#27272   You funny. ) Cannabix is money.. Carthnel 04/21/22 10:50:24 AM
#27271   What I'm telling you is Cannabix is desperate Money $hot 04/21/22 09:33:56 AM
#27270   Trashing again on a good PR, so Carthnel 04/21/22 07:25:51 AM
#27269   Another story to pump with an agreement with Money $hot 04/20/22 09:42:18 AM
#27268   ORIGINAL: Cannabix Technologies Creates Contactless Alcohol Breath Detection High420 04/20/22 09:24:08 AM
#27267   Nice new$ Carthnel 04/20/22 08:51:04 AM
#27266   “With 91% of Americans supporting either medical or tcm55 04/19/22 12:43:58 AM
#27265   Retired Psychologist? EOM Money $hot 04/15/22 01:12:28 PM
#27264   So, you're not invested here anymore and are tcm55 04/15/22 01:09:54 PM
#27263   rotflmao...you can dismiss all other tech all you Money $hot 04/15/22 01:00:03 PM
#27262   Time stamp. tcm55 04/15/22 12:53:28 PM
#27259   Yo Carthnel! Let me know what you think Money $hot 04/15/22 10:14:36 AM
#27258   Yo Carthnel! There will be plenty of news Money $hot 04/15/22 05:20:21 AM
#27257   FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples Money $hot 04/15/22 04:53:37 AM
#27256   I saw this and thought about the medical tcm55 04/14/22 09:25:25 PM
#27255   From around the bend... Money $hot 04/13/22 04:33:50 PM
#27253   Yeah, you got something alright. Something more like Money $hot 04/12/22 11:50:55 AM
#27251   As well, the difference in the models with Carthnel 04/12/22 10:47:31 AM
#27250   The fact I was pointing to is your Carthnel 04/12/22 10:45:03 AM
PostSubject
Consent Preferences